National Health Investors, Inc. (NYSE:NHI) Receives Consensus Recommendation of “Moderate Buy” from Analysts

National Health Investors, Inc. (NYSE:NHI) has received an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $76.60.

Separately, Truist Financial lowered their target price on National Health Investors from $78.00 to $72.00 and set a “hold” rating for the company in a research note on Monday, December 23rd.

National Health Investors Trading Up 0.9 %

Shares of NHI opened at $71.35 on Wednesday. The stock has a fifty day moving average price of $68.59 and a two-hundred day moving average price of $75.08. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. National Health Investors has a 52-week low of $56.70 and a 52-week high of $86.13. The company has a market cap of $3.24 billion, a price-to-earnings ratio of 24.52, a PEG ratio of 4.42 and a beta of 1.06.

National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.03. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. Analysts predict that National Health Investors will post 4.41 EPS for the current fiscal year.

Institutional Investors Weigh In On National Health Investors

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of National Health Investors by 1.6% in the 4th quarter. Vanguard Group Inc. now owns 6,423,210 shares of the real estate investment trust’s stock valued at $445,128,000 after buying an additional 102,012 shares during the period. Principal Financial Group Inc. increased its holdings in National Health Investors by 5.3% in the fourth quarter. Principal Financial Group Inc. now owns 1,648,499 shares of the real estate investment trust’s stock valued at $114,242,000 after purchasing an additional 82,825 shares during the last quarter. Geode Capital Management LLC increased its holdings in National Health Investors by 1.8% in the fourth quarter. Geode Capital Management LLC now owns 1,113,771 shares of the real estate investment trust’s stock valued at $77,201,000 after purchasing an additional 19,201 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in National Health Investors by 2.9% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 876,839 shares of the real estate investment trust’s stock valued at $60,765,000 after purchasing an additional 24,462 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its holdings in National Health Investors by 3.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 634,430 shares of the real estate investment trust’s stock valued at $43,966,000 after purchasing an additional 20,631 shares during the last quarter. 62.51% of the stock is owned by institutional investors and hedge funds.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.